Penumbra Revenue 2014-2018 | PEN
Penumbra annual/quarterly revenue history and growth rate from 2014 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Penumbra revenue for the quarter ending December 31, 2018 was $0.121B, a 25.76% increase year-over-year.
- Penumbra revenue for the twelve months ending December 31, 2018 was $0.445B, a 33.31% increase year-over-year.
- Penumbra annual revenue for 2018 was $0.445B, a 33.31% increase from 2017.
- Penumbra annual revenue for 2017 was $0.334B, a 26.75% increase from 2016.
- Penumbra annual revenue for 2016 was $0.263B, a 41.5% increase from 2015.
| Penumbra Annual Revenue (Millions of US $) |
|
|---|---|
| 2018 | $445 |
| 2017 | $334 |
| 2016 | $263 |
| 2015 | $186 |
| 2014 | $126 |
| 2013 | $89 |
| Penumbra Quarterly Revenue (Millions of US $) |
|
|---|---|
| Q4 2018 | $121 |
| Q3 2018 | $112 |
| Q2 2018 | $110 |
| Q1 2018 | $103 |
| Q4 2017 | $96 |
| Q3 2017 | $84 |
| Q2 2017 | $81 |
| Q1 2017 | $73 |
| Q4 2016 | $73 |
| Q3 2016 | $67 |
| Q2 2016 | $65 |
| Q1 2016 | $58 |
| Q4 2015 | $54 |
| Q3 2015 | $50 |
| Q2 2015 | $42 |
| Q1 2015 | $39 |
| Q4 2014 | $0 |
| Q3 2014 | $32 |
| Q4 2013 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.449B | $0.445B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $107.252B | 24.17 |
| Intuitive Surgical (ISRG) | United States | $64.916B | 60.64 |
| Edwards Lifesciences (EW) | United States | $39.351B | 40.30 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.130B | 16.52 |
| IDEXX Laboratories (IDXX) | United States | $18.856B | 51.34 |
| ABIOMED (ABMD) | United States | $14.122B | 93.22 |
| Teleflex (TFX) | United States | $13.787B | 30.23 |
| Hologic (HOLX) | United States | $13.636B | 20.62 |
| Varian Medical Systems (VAR) | United States | $12.592B | 31.45 |
| DexCom (DXCM) | United States | $11.167B | 427.86 |
| STERIS (STE) | United Kingdom | $10.357B | 26.62 |
| Masimo (MASI) | United States | $7.154B | 44.55 |
| Globus Medical (GMED) | United States | $4.745B | 28.80 |
| Integra LifeSciences Holdings (IART) | United States | $4.697B | 22.77 |
| LivaNova (LIVN) | United Kingdom | $4.646B | 28.64 |
| Tandem Diabetes Care (TNDM) | United States | $3.991B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $3.987B | 0.00 |
| Glaukos (GKOS) | United States | $2.895B | 0.00 |
| Cantel Medical (CMD) | United States | $2.758B | 27.43 |
| Integer Holdings (ITGR) | United States | $2.680B | 21.86 |
| Inogen (INGN) | United States | $2.002B | 39.90 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.941B | 21.08 |
| Nevro (NVRO) | United States | $1.902B | 0.00 |
| OPKO Health (OPK) | United States | $1.551B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $1.144B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.102B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.068B | 29.02 |
| Veracyte (VCYT) | United States | $1.059B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.053B | 199.93 |
| Luminex (LMNX) | United States | $1.050B | 47.98 |
| CryoLife (CRY) | United States | $1.046B | 112.76 |
| Intersect ENT (XENT) | United States | $0.961B | 0.00 |
| Fluidigm (FLDM) | United States | $0.960B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.870B | 35.59 |
| Natus Medical (BABY) | United States | $0.865B | 18.03 |
| AxoGen (AXGN) | United States | $0.834B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.813B | 26.36 |
| ViewRay (VRAY) | United States | $0.779B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.661B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.564B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.462B | 48.72 |
| TransEnterix (TRXC) | United States | $0.456B | 0.00 |
| Si-Bone (SIBN) | United States | $0.456B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.408B | 0.00 |
| Accuray (ARAY) | United States | $0.408B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.388B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.377B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.352B | 51.36 |
| IRadimed (IRMD) | United States | $0.309B | 65.42 |
| SeaSpine Holdings (SPNE) | United States | $0.282B | 0.00 |
| Sientra (SIEN) | United States | $0.277B | 0.00 |
| Neuronetics (STIM) | United States | $0.262B | 0.00 |
| Nuvectra (NVTR) | United States | $0.220B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.188B | 43.67 |
| ConforMIS (CFMS) | United States | $0.181B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.160B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.152B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.122B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.121B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.119B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.115B | 0.00 |
| SOLITON INC (SOLY) | $0.105B | 0.00 | |
| Second Sight Medical Products (EYES) | United States | $0.103B | 0.00 |
| Vermillion (VRML) | United States | $0.093B | 0.00 |
| EDAP TMS (EDAP) | France | $0.083B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.076B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.075B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.065B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.050B | 0.00 |
| Electromed (ELMD) | United States | $0.045B | 23.13 |
| Viveve Medical (VIVE) | United States | $0.044B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.037B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.036B | 0.00 |
| Avinger (AVGR) | United States | $0.036B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.034B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.029B | 0.00 |
| PAVmed (PAVM) | United States | $0.028B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.027B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.026B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.025B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.022B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.020B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.020B | 65.67 |
| Dynatronics (DYNT) | United States | $0.016B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.016B | 12.44 |
| ReWalk Robotics (RWLK) | Israel | $0.015B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.015B | 0.00 |
| Presbia (LENS) | Ireland | $0.013B | 0.00 |
| Neovasc (NVCN) | Canada | $0.012B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
